San Luis Wealth Advisors LLC Buys New Stake in Kenvue Inc. $KVUE

Key Points

• San Luis Wealth Advisors bought 52,880 Kenvue shares worth approximately $1.01 million during the second quarter, while institutional investors collectively own 97.64% of the company.
• Analysts maintain a consensus “Hold” rating on KVUE, with an average price target of $19.27; recent firms generally kept neutral ratings while adjusting targets between $18 and $19.
• Kenvue reported quarterly EPS of $0.31 and revenue of $3.96 billion, slightly below analyst estimates, while revenue increased 3% year over year. The company pays a quarterly dividend of $0.21 per share, implying a 4.4% yield.

San Luis Wealth Advisors LLC bought a new stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 52,880 shares of the company's stock, valued at approximately $1,011,000.

A number of other large investors have also recently bought and sold shares of the stock. Arrowstreet Capital Limited Partnership acquired a new position in shares of Kenvue in the second quarter worth $6,528,000. Jump Financial LLC boosted its stake in shares of Kenvue by 210.6% during the second quarter. Jump Financial LLC now owns 54,823 shares of the company's stock valued at $1,147,000 after acquiring an additional 37,170 shares during the last quarter. AXA S.A. increased its position in Kenvue by 21.1% during the 2nd quarter. AXA S.A. now owns 48,892 shares of the company's stock worth $1,023,000 after purchasing an additional 8,524 shares in the last quarter. NewEdge Advisors LLC increased its position in Kenvue by 219.1% during the 2nd quarter. NewEdge Advisors LLC now owns 97,481 shares of the company's stock worth $2,040,000 after purchasing an additional 66,930 shares in the last quarter. Finally, The Manufacturers Life Insurance Company raised its stake in Kenvue by 0.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company's stock valued at $39,217,000 after purchasing an additional 10,885 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Analyst Ratings Changes

A number of research firms have issued reports on KVUE. Citigroup reduced their target price on shares of Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a report on Wednesday, April 15th. Wall Street Zen downgraded shares of Kenvue from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Barclays boosted their price objective on shares of Kenvue from $18.00 to $19.00 and gave the company an "equal weight" rating in a research report on Tuesday, July 21st. UBS Group reduced their price objective on shares of Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a research note on Tuesday. Finally, Weiss Ratings upgraded shares of Kenvue from a "hold (c-)" rating to a "hold (c)" rating in a research report on Monday, June 15th. Three equities research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $19.27.

Kenvue Stock Performance

Kenvue stock opened at $18.97 on Thursday. The stock has a fifty day moving average price of $18.88 and a 200 day moving average price of $18.12. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $21.95. The firm has a market capitalization of $36.44 billion, a P/E ratio of 21.80, a PEG ratio of 1.36 and a beta of 0.47. The company has a current ratio of 1.01, a quick ratio of 0.71 and a debt-to-equity ratio of 0.67.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.31 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.32 by ($0.01). The business had revenue of $3.96 billion during the quarter, compared to analyst estimates of $3.97 billion. Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The firm's quarterly revenue was up 3.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.29 earnings per share. Equities research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 26th. Stockholders of record on Wednesday, August 12th will be issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 4.4%. The ex-dividend date is Wednesday, August 12th. This is an increase from Kenvue's previous quarterly dividend of $0.21. Kenvue's payout ratio is currently 95.40%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source